MX2010004505A - Piperidinas 4,4-disustituidas. - Google Patents
Piperidinas 4,4-disustituidas.Info
- Publication number
- MX2010004505A MX2010004505A MX2010004505A MX2010004505A MX2010004505A MX 2010004505 A MX2010004505 A MX 2010004505A MX 2010004505 A MX2010004505 A MX 2010004505A MX 2010004505 A MX2010004505 A MX 2010004505A MX 2010004505 A MX2010004505 A MX 2010004505A
- Authority
- MX
- Mexico
- Prior art keywords
- disubstituted piperidines
- piperidines
- disubstituted
- salts
- medicines
- Prior art date
Links
- -1 4,4-disubstituted piperidines Chemical class 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000002461 renin inhibitor Substances 0.000 abstract 1
- 229940086526 renin-inhibitors Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
La solicitud se refiere a piperidinas 4,4-disustituidas de la fórmula general (I): (ver fórmula I) y a sus sales, de preferencia a sus sales farmacéuticamente aceptables, en donde R2 tiene los significados explicados en la descripción; a un proceso para su preparación, y al uso de estos compuestos como medicamentos, en especial como inhibidores de renina.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07119265 | 2007-10-25 | ||
| PCT/EP2008/064417 WO2009053452A1 (en) | 2007-10-25 | 2008-10-24 | 4,4-disubstituted piperidines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010004505A true MX2010004505A (es) | 2010-05-13 |
Family
ID=38988569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010004505A MX2010004505A (es) | 2007-10-25 | 2008-10-24 | Piperidinas 4,4-disustituidas. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20110212950A1 (es) |
| EP (1) | EP2212317A1 (es) |
| JP (1) | JP2011500766A (es) |
| KR (1) | KR20100085124A (es) |
| CN (1) | CN101835775A (es) |
| AR (1) | AR069005A1 (es) |
| AU (1) | AU2008316484A1 (es) |
| CA (1) | CA2703593A1 (es) |
| EA (1) | EA201000611A1 (es) |
| MX (1) | MX2010004505A (es) |
| TW (1) | TW200922596A (es) |
| WO (1) | WO2009053452A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009078481A1 (ja) | 2007-12-19 | 2009-06-25 | Dainippon Sumitomo Pharma Co., Ltd. | 二環性へテロ環誘導体 |
| WO2010068697A2 (en) * | 2008-12-09 | 2010-06-17 | Datalogic Scanning, Inc. | Systems and methods for reducing weighing errors associated with partially off-scale items |
| US8658639B2 (en) | 2009-06-24 | 2014-02-25 | Dainippon Sumitomo Pharma Co., Ltd | N-substituted-cyclic amino derivative |
| AU2019387370A1 (en) | 2018-11-30 | 2021-06-10 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL123293A (en) * | 1995-09-07 | 2003-06-24 | Hoffmann La Roche | Piperidine derivatives, their preparation and pharmaceutical compositions containing them |
| TW200513461A (en) * | 2003-10-01 | 2005-04-16 | Speedel Experimenta Ag | Organische verbindungen |
| TW200613274A (en) * | 2004-07-09 | 2006-05-01 | Speedel Experimenta Ag | Organic compounds |
| TW200722424A (en) * | 2005-03-31 | 2007-06-16 | Speedel Experimenta Ag | Substituted piperidines |
| TW200716622A (en) * | 2005-03-31 | 2007-05-01 | Speedel Experimenta Ag | Substituted piperidines |
| AR068887A1 (es) * | 2007-10-18 | 2009-12-16 | Speedel Experimenta Ag | Piperidinas trisustituidas |
-
2008
- 2008-10-23 TW TW097140575A patent/TW200922596A/zh unknown
- 2008-10-23 AR ARP080104621A patent/AR069005A1/es unknown
- 2008-10-24 WO PCT/EP2008/064417 patent/WO2009053452A1/en not_active Ceased
- 2008-10-24 EA EA201000611A patent/EA201000611A1/ru unknown
- 2008-10-24 KR KR1020107011221A patent/KR20100085124A/ko not_active Withdrawn
- 2008-10-24 AU AU2008316484A patent/AU2008316484A1/en not_active Abandoned
- 2008-10-24 CA CA2703593A patent/CA2703593A1/en not_active Abandoned
- 2008-10-24 EP EP08842768A patent/EP2212317A1/en not_active Withdrawn
- 2008-10-24 JP JP2010530466A patent/JP2011500766A/ja active Pending
- 2008-10-24 CN CN200880112511A patent/CN101835775A/zh active Pending
- 2008-10-24 US US12/734,321 patent/US20110212950A1/en not_active Abandoned
- 2008-10-24 MX MX2010004505A patent/MX2010004505A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008316484A1 (en) | 2009-04-30 |
| EP2212317A1 (en) | 2010-08-04 |
| TW200922596A (en) | 2009-06-01 |
| KR20100085124A (ko) | 2010-07-28 |
| JP2011500766A (ja) | 2011-01-06 |
| AR069005A1 (es) | 2009-12-23 |
| EA201000611A1 (ru) | 2010-10-29 |
| CN101835775A (zh) | 2010-09-15 |
| WO2009053452A1 (en) | 2009-04-30 |
| CA2703593A1 (en) | 2009-04-30 |
| US20110212950A1 (en) | 2011-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2011012017A (es) | Nuevos derivados azaciclicos como inhibidores de lipasa sensible a las hormonas (hsl). | |
| MX2010006799A (es) | Benzofuropirimidinonas como inhibidores de la proteina cinasa. | |
| MY149731A (en) | Compounds | |
| PT2178881E (pt) | Novos derivados de 6-triazolopiridazina-sulfanil benzotiazole e benzimidazole, seu método de preparação, sua aplicação como medicamentos, composições farmacêuticas e nova utilização como inibidores de met | |
| TW200613274A (en) | Organic compounds | |
| MY148258A (en) | Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments | |
| GEP20125487B (en) | Organic compounds and their use | |
| MX2009003939A (es) | Derivados de imidazolona e imidazolidinona como inhibidores de la 11-beta-hidroxiesteroide deshidrogenasa de tipo 1 para diabetes. | |
| MX2007003546A (es) | Derivados de indozolona como inhibidores de 11-beta- hidroxiesteroide-deshidrogenasa. | |
| MX2010005824A (es) | Derivados de aminotiazol. | |
| MX2009013501A (es) | Compuestos piperidinicos y sus usos. | |
| UA99787C2 (en) | Lactams as beta secretase inhibitors | |
| MX2010006108A (es) | Inhibidores de estearoil-coa-desaturasa. | |
| TN2010000038A1 (en) | Organic compounds | |
| WO2011047055A3 (en) | Novel mek inhibitors, useful in the treatment of diseases | |
| GEP20125407B (en) | New process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2h-3- benzazepin-2-one, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | |
| MY143568A (en) | 11b-hsd1 inhibitors for the treatment of diabetes | |
| DE602006021539D1 (en) | Morpholine als 5ht2c-agonisten | |
| WO2009126861A3 (en) | Triazolopyridine compounds useful as dgat1 inhibitors | |
| NO20085052L (no) | 4-((fluorofenoksyl)fenylmetyl)piperidin metansulfonat: anvendelser, synteseprosess og farmasoytiske sammensetninger | |
| TW200616958A (en) | New alkyl-pyridines as 11-beta inhibitors for diabetes | |
| MY161749A (en) | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | |
| TW200702330A (en) | 3,4,5-Substituted piperidines | |
| MX2009012518A (es) | Derivados de piperidina 4,4-disubstituidos. | |
| WO2008087654A3 (en) | PIPERIDINES AS INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |